Hiroshi Narita, Ph.D.

Dr. Narita is currently General Manager in the Research Strategy & Planning Department of the Research Division of Mitsubishi Tanabe Pharma Corporation (MTPC). He joined Tanabe Seiyaku Co. Ltd. in 1976 and has over 30 years experience in pharmacology and drug discovery. His research area is cardiovascular pharmacology, and he has been involved in the development of many drugs such as calcium antagonists, ACE inhibitors, and beta-blockers. He spent one year as a General Manager of Exploratory Toxicology and DMPK Research Laboratories, and three years as a General Manager of Pharmacology Research Laboratories. MTPC was formed through the merger of Tanabe Seiyaku Co., Ltd., and Mitsubishi Pharma Corporation on October 1, 2007.


Yutaka Hino

Mr. Hino is currently General Manager of the Research Coordination & Administration Department of MTPC. He has worked in the Pharmacological Research Laboratory, Research Strategy & Planning Department and in Research Coordination & Administration since he joined the company. His main experience is in Portfolio Management, Allocation of Management Resources, External Affairs and Personnel Affairs, including management training. He was transferred to the US as Licensing Officer for four years and in the first year of his stay, he worked at TRL in San Diego (as a former Tanabe employee, not as a TRL employee). Returning to Japan, he engaged in M&A operations and corporate structural reform in the Corporate Strategic Planning Division. After the merger of Tanabe and Mitsubishi in 2007, he moved to his current position. He has been serving as a TRL Director since April 2007.


Masaki Yamada, Ph.D., M.B.A.

Dr. Yamada joined Tanabe Seiyaku in 1985. He has more than 20 years of experience in drug discovery and medicinal chemistry. From 1991 to 1992, he spent one year at Tanabe Research Laboratories (TRL) in San Diego as a research assistant, so he is an alumnus of TRL. After he received his MBA in 2002, he transferred from the Research Laboratory to the Strategic Research Planning Division. At present, he manages research projects, portfolio and alliances in Mitsubishi Tanabe Pharma Corporation (MTPC). MTPC was formed through the merger of Tanabe Seiyaku Co., Ltd., and Mitsubishi Pharma Corporation on October 1, 2007.